|The image shows cisplatin crystals, |
which is a platinum compound,
and used as a chemotherapy drug
Since drugs that inhibit MK2 are already available and approved for use to treat inflammatory diseases such as arthritis it is hoped that combining these drugs with current chemotherapy treatments could greatly improve the efficacy of these treatments. The potential combination is not an obvious choice as the usual combinations chosen for cancer treatment each have anti-tumor effects individually, while in this case the MK2 inhibitor does not directly affect cancer growth alone.
Some information for this blog was obtained from the Science Daily article: Biologists ID New Cancer Weakness